April 10, 2021

Santen SA and Sydnexis Inc. announce the signing of an exclusive licensing agreement for SYD-101.

January 27, 2020

GMAC’s mission is to promote public awareness of childhood myopia as a treatable disease

May 2, 2019

Announcing the Enrollment of First Patients in Phase 3 Myopia STAAR Study of SYD-101 in Children